EMCDDA expert meeting on the epidemiological indicator Drug-related deaths (DRD)

Source: European Drug Report 2019

On 21-22 October 2019, the EMCDDA brings together more than fifty European and international experts for a meeting on the key indicator Drug-related deaths. The meeting provides a space for sharing and discussing new data, studies and experiences at regional, national and European level.

It also aims to facilitate technical work around the collection and analysis of the different components of this indicator: overdose and toxicological information from special mortality registers; data from the general mortality registers; mortality cohort studies; as well as developments in responses. It includes presentations from experts from EU Member States, neighbouring countries, Australia and the United States. Main findings and report will be available soon after the meeting.

Meeting topics

This year particular attention is given to:

  • Most recent data and concerns reported by the network
  • Post mortem toxicology practices across Europe
  • Deaths related to synthetic opioids and to prescription opioids
  • NPS-related deaths
  • Most recent trends and analysis of MDMA and cocaine-related deaths
  • Drug consumption rooms and naloxone programmes to reduce overdose deaths

Main findings

A summary of key points will be available shortly after the meeting.

Presentations

Downloads  

Session 2 - MDMA and other recreational drugs: joint perspective on recent trends from the ‘Mortality’ and the ‘Drug checking’ networks

generic

Session 4 - Opioid‐related deaths and deaths related to (other) medicines / ‘DRD dashboard’ project

multilingual

Session 7 - Responses to reduce drug‐related overdose morbidity and to prevent drug‐related deaths

generic

Session 8 - Updates on the DRD cross validation underestimation project

generic

Session 9 - IPA 7 Coordination meeting DRD experts 2019 ‐ for experts from the Western Balkan countries only

generic
Loading